| Literature DB >> 30605714 |
Jing Liu1, Haizhou Zhu1, Gurdat Premnauth2, Kaylin G Earnest1, Patricia Hahn1, George Gray1, Jack A Queenan3, Lisa E Prevette3, Safnas F AbdulSalam1, Ana Luisa Kadekaro4, Edward J Merino5.
Abstract
UV irradiation is a major driver of DNA damage and ultimately skin cancer. UV exposure leads to persistent radicals that generate ROS over prolonged periods of time. Toward the goal of developing long-lasting antioxidants that can penetrate skin, we have designed a ROS-initiated protective (RIP) reagent that, upon reaction with ROS (antioxidant activity), self-cyclizes and then releases the natural product apocynin. Apocynin is a known antioxidant and inhibitor of NOX oxidase enzymes. A key phenol on the compound 1 controls ROS-initiated cyclization and makes 1 responsive to ROS with a EC50 comparable to common antioxidants in an ABTS assay. In an in vitro DNA nicking assay, the RIP reagent prevented DNA strand breaks. In cell-based assays, the reagent was not cytotoxic, apocynin was released only in cells treated with UVR, reduced UVR-induced cell death, and lowered DNA lesion formation. Finally, topical treatment of human skin explants with the RIP reagent reduced UV-induced DNA damage as monitored by quantification of cyclobutane dimer formation and DNA repair signaling via TP53. The reagent was more effective than administration of a catalase antioxidant on skin explants. This chemistry platform will expand the types of ROS-activated motifs and enable inhibitor release for potential use as a long-acting sunscreen.Entities:
Keywords: Antioxidant; Apocynin; Melanoma; ROS; Radical; Reactive oxygen species; Sunscreen; UV
Mesh:
Substances:
Year: 2018 PMID: 30605714 DOI: 10.1016/j.freeradbiomed.2018.12.037
Source DB: PubMed Journal: Free Radic Biol Med ISSN: 0891-5849 Impact factor: 7.376